Sawai Group Holdings Co., Ltd. (TYO:4887)

CTI BioPharma Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	38,785	26,368	33,076	47,717	54,269
Short-Term Investments	-	-	-	146	143
Cash & Short-Term Investments	38,785	26,368	33,076	47,863	54,412
Cash Growth	47.09%	-20.28%	-30.89%	-12.04%	-3.22%
Receivables	48,879	57,205	67,007	65,059	70,107
Inventory	109,867	100,002	101,805	85,853	79,120
Other Current Assets	3,292	56,410	3,459	3,348	2,035
Total Current Assets	200,823	239,985	205,347	202,123	205,674
Property, Plant & Equipment	111,876	103,400	121,330	111,218	84,708
Long-Term Investments	4,597	9,320	10,220	7,223	6,409
Goodwill	-	-	-	-	39,304
Other Intangible Assets	27,196	20,299	27,096	17,162	42,083
Long-Term Deferred Tax Assets	10,132	9,020	173	346	1,766
Long-Term Deferred Charges	-	-	-	9,127	12,389
Other Long-Term Assets	-1	-	-1	2,303	1,008
Total Assets	354,623	382,024	364,165	349,502	393,341
Accounts Payable	50,777	45,622	52,815	28,665	27,545
Accrued Expenses	1,586	987	3,442	7,570	7,987
Short-Term Debt	7,157	12,848	10,000	-	-
Current Portion of Long-Term Debt	14,346	3,201	3,034	13,116	3,834
Current Portion of Leases	1,413	1,379	1,449	1,590	1,279
Current Income Taxes Payable	5,334	6,952	5,411	3,430	3,355
Other Current Liabilities	22,202	6,361	9,003	34,469	36,452
Total Current Liabilities	102,815	77,350	85,154	88,840	80,452
Long-Term Debt	69,836	66,841	60,098	53,633	66,741
Long-Term Leases	2,355	2,858	2,492	2,889	2,770
Long-Term Deferred Tax Liabilities	137	337	2,092	2,303	58
Other Long-Term Liabilities	5,626	16,607	1,591	1,754	2,570
Total Liabilities	180,769	163,993	151,427	149,419	152,591
Common Stock	10,053	10,020	10,000	10,000	41,219
Additional Paid-In Capital	37,767	37,734	37,714	73,672	42,453
Retained Earnings	157,257	149,645	141,642	98,709	132,429
Treasury Stock	-33,243	-2	-2	-2	-
Comprehensive Income & Other	2,020	15,265	12,289	7,688	2,177
Total Common Equity	173,854	212,662	201,643	190,067	218,278
Minority Interest	-	5,369	11,095	10,016	22,472
Shareholders' Equity	173,854	218,031	212,738	200,083	240,750
Total Liabilities & Equity	354,623	382,024	364,165	349,502	393,341
Total Debt	95,107	87,127	77,073	71,228	74,624
Net Cash (Debt)	-56,322	-60,759	-43,997	-23,365	-20,212
Net Cash Per Share	-452.89	-461.11	-334.15	-177.85	-153.70
Filing Date Shares Outstanding	115.45	131.41	131.37	131.37	131.37
Total Common Shares Outstanding	115.45	131.41	131.37	131.37	131.37
Working Capital	98,008	162,635	120,193	113,283	125,222
Book Value Per Share	1505.86	1618.32	1534.89	1446.77	1661.50
Tangible Book Value	146,658	192,363	174,547	172,905	136,891
Tangible Book Value Per Share	1270.30	1463.85	1328.64	1316.14	1041.99
Land	-	-	-	12,031	12,040
Buildings	-	-	-	80,067	63,860
Machinery	-	-	-	89,148	82,446
Construction In Progress	-	-	-	23,157	10,944

Source: S&P Global Market Intelligence. Standard template. Financial Sources.